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Introduction: Thyroid nodules are the most common endocrine condition treated by surgeons. The main 
purpose of the evaluation of a thyroid nodule is to rule out a carcinoma. Medical decisions concerning 
thyroid nodules are highly influenced by subjective beliefs.
Objective: To assess the subjective probabilities of malignancy that are assigned to the clinical 
characteristics of a patient with a thyroid nodule in order to determine the degree of influence that these 
probabilities have on the final clinical suspicion of malignancy compared with objective data.
Material and methods: A bayesian analysis was designed to predict the risk of malignancy of a thyroid 
nodule based on the causal relationship between the demographic and clinical risk factors that are 
detected during the first consultation. A model with demographic and clinical variables using general 
surgeons as experts was developed.
Results: The highest probability of malignancy (94%) was assigned to the pooled case of a male 
who was older than 60 years, with dysphonia, dysphagia, accelerated growth rate of the nodule and 
previous neck radiotherapy and who had a relative with thyroid cancer as well as multiple nodules that 
were larger than 1 cm and with hard consistency and palpable neck lymph nodes. For low risk cases 
in which the nodule characteristics are not suggestive of malignancy, the probability of malignancy 
assigned by clinicians was 33.59%; for high risk cases this was 75.54%.
Conclusion: Surgeons make diagnostic decisions based on subjective beliefs that do not necessarily 
correspond to the objective measures of the characteristics of the nodules.
Key words: thyroid nodule, Bayes theorem, thyroid neoplasm; models, statistical; probability; health 
knowledge, attitudes, practice.
Los cirujanos sobreestiman el riesgo de malignidad de los nódulos tiroideos, evaluación de los 
estimados subjetivos usando un análisis bayesiano
Introducción. Los nódulos tiroideos son la condición endocrina más frecuente para los cirujanos. El 
principio de la evaluación de un nódulo tiroideo es determinar si éste corresponde a un carcinoma. Las 
decisiones médicas sobre los nódulos tiroideos son influenciadas fuertemente por consideraciones 
subjetivas.
Objetivo. Determinar las probabilidades subjetivas asignadas a las características clínicas de un 
paciente con un nódulo tiroideo, para evaluar el grado de influencia de estas probabilidades en la 
sospecha clínica final de un proceso maligno en comparación con los datos objetivos.
Materiales y métodos. Se diseñó un análisis bayesiano para predecir el riesgo de un proceso maligno 
en un nódulo tiroideo, con base en la relación causal conocida de los factores clínicos y los demográficos 
durante la primera consulta. Se desarrolló un modelo con las variables clínicas y demográficas usando 
como expertos a los cirujanos. 
Resultados. La mayor probabilidad de un proceso maligno (94 %) se asignó al caso clínico de un 
hombre mayor de 60 años, con disfonía y disfagia, nódulo de crecimiento rápido, antecedentes de 
radioterapia cervical y familiar con cáncer de tiroides, con nódulos múltiples, mayores de 1 cm, de 
consistencia dura y con adenomegalias cervicales palpables. Para los casos de bajo riesgo, con 
nódulos sin características de un proceso maligno, la probabilidad de éste asignada por los clínicos 
fue de 33,59 % y para los de alto riesgo de 75,54 %.
Conclusión. Los cirujanos toman decisiones diagnósticas basadas en creencias subjetivas que no 
necesariamente corresponden con los datos objetivos de las características de nódulos. 
Palabras clave: nódulo tiroideo, teorema de Bayes, neoplasias de la tiroides, modelos estadísticos, 
probabilidad; conocimientos, actitudes y práctica en salud
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Thyroid nodules are the most common endocrine 
condition treated by surgeons. Five percent of 
individuals will have a thyroid nodule detected 
by physical examination, and this number can 
increase up to 35% if ultrasonography is used (1-3). 
The objective of evaluating a thyroid nodule is to 
determine if the nodule is a carcinoma or an adenoma. 
In carcinomas, a partial or total thyroidectomy is 
indicated. In adenomas, ultrasonographic follow-
up is adequate.
Classically, some clinical variables have been 
associated with a greater risk of malignancy when 
present in a patient with thyroid nodules (4). An 
age greater than 45 years increases the risk of 
malignancy in 2 to 4% of patients with thyroid 
nodules, the male gender in 5-6%, previous 
radiotherapy in 1 to 7%, a family history of thyroid 
cancer in 8% and solitary and hard nodules larger 
than 4 cm and lateral lymph nodes in 6 to 8%. 
Progressive growth and obstructive symptoms have 
not been linked to an increased risk of malignancy 
in recent studies (5-8). The weight surgeons give to 
these findings, known as subjective probabilities, 
may influence their decision to perform a fine 
needle aspiration biopsy (FNAB) rather than follow 
the nodule over time. Subjective probabilities are 
the numeric expression of the experts’ beliefs 
about the probability of the occurrence of an event. 
Uncertainty in subjective probabilities is associated 
with the lack of sufficient data to allow a better 
understanding and quantification of variables that 
could be useful to create a predictive model (9).
Medical decisions concerning patients with thyroid 
nodules are highly influenced by subjective 
probabilities; diagnostic and therapeutic measures 
are taken based on these probabilities. Given the 
high incidence of thyroid nodules and the known 
increase in the diagnosis of small-sized nodules (10), 
it is important to assess the subjective probabilities 
that surgeons associate with malignancy in order to 
propose strategies to use resources cost-effectively.
A bayesian analysis was selected to assess the 
subjective probabilities that surgeons associate 
with a higher risk of malignancy in a thyroid nodule 
and which was based on the causal relationship of 
demographic and clinical risk factors that are usually 
evaluated during a consultation and physical exam. 
The advantage of the bayesian approach in the 
analysis of judgments is that it provides a systematic 
procedure to update subjective judgments or 
degrees of confidence using new information, 
groupings or by combining knowledge to make 
decisions (11). The departure point for bayesian 
analysis is the a priori probability that represents 
the degree of confidence that the researcher has in 
a hypothesis before considering new information. 
This a priori probability is combined with new 
information using Bayes’ theorem, which results 
in a probability a posteriori. Bayesian networks 
(or belief networks) is a methodology used to 
model and simulate the behavior of discrete-event 
systems under uncertainty (12).
The aim of this study was to assess the subjective 
probabilities assigned to the clinical characteristics 
of a patient who presented with a thyroid nodule 
to determine the degree of influence that these 
subjective probabilities have on the final clinical 
suspicion of malignancy and to compare this 
probability to real data based on disease incidence. 
This study only analyzed the diagnostic phase of 
the disease.
Material and methods
A bayesian analysis was selected to assess the 
surgeon’s beliefs that are associated with a higher 
risk of malignancy in a thyroid nodule. We followed 
five steps to develop the model:
  1)  the identification of variables with uncertainty; 
  2)   the design of instruments to estimate subjective 
     probabilities; 
  3) the selection and training of experts; 
  4) the quantification of subjective probabilities;   
 and 
  5) the pooling of subjective probabilities into a 
     predictive model. 
The first three steps were performed by the authors. 
We selected general surgeons with a current 
practice in thyroid surgery and who participated in 
academic activities during the Colombian National 
Congress of Surgery of 2008.
To identify the variables to be included in the model, 
we followed the uncertainty matrix developed by 
Walker, et al. (13). A literature review was conducted 
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to determine the risk factors for malignancy in a 
thyroid nodule, and the variables that have been 
reported as clinically useful were selected (6-8,14-
19). This review identified gender, age, family history 
of thyroid cancer, previous radiotherapy in the 
head and neck, the number, size and consistency 
of thyroid nodules, the growth rate of the nodule, 
dysphagia and dysphonia and the finding of lateral 
neck lymph nodes as clinically relevant variables 
related with the risk of malignancy. 
The variables selected were validated with two head 
and neck surgeons who provided insight regarding 
the ease with which variables could be collected in 
a clinical setting. These variables were categorized 
into five groups according to the normal steps 
followed during the recording of clinical data on the 
medical record: demographic data (gender and age); 
medical history (previous neck radiotherapy, familiar 
cases of thyroid carcinoma), associated symptoms 
(dysphagia, dysphonia, the growth rate of the nodule), 
thyroid nodule characteristics at physical examination 
(number of nodules, size and consistency) and the 
finding of lateral neck lymph nodes, and introduced in 
the bayesian network (figure 1). 
We considered high risk to include old age, male 
gender, previous neck radiotherapy, a family 
history of thyroid cancer, the associated symptoms 
of dysphagia and dysphonia, the growth rate of 
the nodule, a solitary nodule, size >2 cm, a hard 
consistency and the presence of lateral lymph 
nodes. This approach obtains the risk level 
associated with each variable, the corresponding 
group and the entire network.
This network included an estimate of 104 conditional 
probabilities. The authors designed 32 clinical cases 
and 20 control questions presented in individual 
cards to assess the subjective probabilities of the 
selected risk factors using a probability scale as 
an outcome (table 1). These cases were designed 
by one of the authors following the clinical path 
that is commonly used in the surgical community 
(identification of the patient, signs and symptoms, 
previous diseases and findings upon physical 
examination). Each case diverges in the value of only 
one variable (low or high risk) as previously defined.
Table 1. Example of a clinical 
case designed for evaluation of 
probabilities
Case 
It was a male patient, 60 years-
old, with a stable thyroid nodule 
and without any other symptoms. 
He received radiotherapy on the 
neck 5 years before because of a 
lymphoma. He had a family history 
of thyroid cancer. At the physical 
exam he had a thyroid nodule of 
0.5 cm diameter, soft consistency 
and a lateral neck lymph node of 
2 cm. 
Based in the clinical picture, we 
defined in a percentage scale, 
the probability of malignancy of 
this thyroid nodule, being 0% 
the minimum level and 100% the 
maximal level of malignancy. 
Value: %
100%
50%
0%
Figure 1. Bayesian network.
Gender
Previous radiotherapy
Medical history
Associated
symptoms
Nodule growth rate
Nodule size
Nodule consistency
Number of nodules
Lateral neck lymph nodes
Family history of
thyroid cancer
Suspicion of
malignancy in a
thyroid nodule
Nodule
characteristics
Dysphagia/dysphoni
Age
Initial state
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history, the clinical characteristics of the nodule or 
the associated symptoms. The highest probability 
of malignancy (87%) was assigned to the case of 
fast growing nodule in a patient with dysphagia and 
dysphonia.
Table 4 provides the combined probabilities that 
a physician assigned to patients with thyroid 
nodules in which the surgeon knew the value of all 
of the clinical variables for each group as defined 
previously. For example, in table 4, row 1, a male 
patient who was older than 60 years, with dysphonia 
and dysphagia, with multiple hard nodules that 
were larger than 1 cm with an accelerated growth 
rate and with palpable neck lymph nodes and who 
received neck radiotherapy and with a relative with 
thyroid cancer, had a probability of malignancy of 
94%. For this step, the number of probabilities was 
sizeable, so we grouped risk factors as high or low 
risk for malignancy in a thyroid nodule using the 
classically accepted clinical criteria described in 
the material and methods section.
Because a priori probabilities do not necessarily 
consider the influence of one variable on the 
value of the other variables and because a 
priori probabilities are analyzed in isolation, it is 
necessary to build a bayesian network, which 
calculates a final probability (a posteriori) based 
on the previously assigned probability for each 
element of the net. For example, a physician could 
consider that an older male patient has a probability 
of malignancy of 35%, as seen in table 3, row 1, but 
when he considers the addition of new information 
about the characteristics of the nodule, such as a 
hard consistency and a size larger than 1 cm, he 
could assign a new probability of 80%, influenced 
by the new information, and without considering 
the previous probability, which should be used as a 
starting point to change the initial probability. 
The bayesian network enables for updating the 
probabilities of malignancy when new patient data 
Table 2. Weight assigned according to level of medical training and years of practice
Code Criteria Rating 
C1 Education  0.15 
C2 Professional experience  0.15 
C3 Research and activities of consultancy in related problems or studies  0.15 
C4 Participation in professional societies 0.08 
C5 Publications 0.08 
C6 Prizes and other indicators of recognition 0.075 
C7 Ability to apply its knowledge 0.075 
C8 Referencing  0.075 
C9 Ability to determine how its field will evolve in the future 0.075
To avoid overwhelming each expert with work, 
we assembled three focus groups with three 
experts per group and assigned 16 clinical cases 
and 10 control questions in a random pattern to 
each expert. Each expert was previously trained 
regarding the methodology and probable bias that 
could affect the procedure. Instructions included 
hierarchizing cards by risk level, from highest to 
lowest, estimating the probabilities at the end of 
each case and answering control questions first, 
followed by the questions for the clinical cases. 
The pooling of probabilities from different experts 
was performed using a linear combination method. 
With       representing the ith function of probability 
density and    as the weight associated with ith 
expert opinion,             and;
and; therefore, the common linear opinion of the 
expert is the weighted mean of the densities, 
For this analysis, the grade of expertise of a 
physician was calculated according to both the 
level of medical training and the years of clinical 
practice (table 2).
The pooled analysis was made using Hugin-Lite 
software (Hugin Expert AVS, Denmark).
Results
The pooled a priori probabilities of different experts 
for the individual variables and clinical cases are 
shown in tables 3 and 4. Table 3 shows the probability 
of malignancy that a surgeon assigned to a patient 
with a thyroid nodule in which the surgeon only knew 
the selected variables for each group as defined 
previously. For example, in table 3, row 1, a male 
patient who was older than 60 years with a thyroid 
nodule was assigned a probability of malignancy of 
35 % without the surgeon knowing the medical 
 pi (q)    
wi > 0
p(q) = wi pi (q)∑
n
i=1
wi=∑
n
i=1
1
wi
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Table 3. Probabilities for individual risk factors *
Patient’s risk factors  Pooled probability 
1 Gender: male; age: old age 0.35 
2 Gender: male; age: middle age 0.25 
3 Gender: female; age: old age 0.32 
4 Gender: female; age: middle age  0.19 
5 Familiar history: yes; radiotherapy: yes  0.8 
6 Familiar history: yes; radiotherapy: no  0.35 
7 Familiar history: no, radiotherapy: yes  0.32 
8 Familiar history: no; radiotherapy: no  0.25 
9 Nodule’s number: multiple; nodule’s volume >2 cm; consistency: hard 0.2 
10 Nodule’s number: multiple; nodule’s volume >2 cm; consistency: soft 0.13 
11 Nodule’s number: multiple; nodule’s volume <1 cm; consistency: hard 0.33 
12 Nodule’s number: multiple; nodule’s volume <1 cm; consistency: soft 0.2 
13 Nodule’s number: single; nodule’s volume >2 cm; consistency: hard 0.37 
14 Nodule’s number: single; nodule’s volume >2 cm; consistency: soft 0.08 
15 Nodule’s number: single; nodule’s volume <1 cm; consistency: hard 0.35 
16 Nodule’s number: single; nodule’s volume <1 cm; consistency: soft 0.09 
17 Dysphagia and dysphonic: does not exist; growth rate: fast 0.73 
18 Dysphagia and dysphonic: exists; growth rate: stable 0.8 
19 Dysphagia and dysphonic: exists; growth rate: fast 0.87 
20 Dysphagia and dysphonic: does not exist; growth rate: stable 0.33
*Only the cases of expected high incidence of malignancy are shown. The number shows the pooled probability an expert assigns 
to a patient consulting with the risk factors described in each row. 
appear and combines all probabilities, including the 
previous one (a priori probability) and the influences 
that the new data have on calculating a posteriori 
probability. Figure 2 shows the final results of the 
bayesian network, divided into low or high risk of 
malignancy groups according to the classically 
accepted risk factors. For the cases of low risk 
(right side) in which the patient’s characteristics 
are not suggestive of malignancy based on known 
clinical factors, the global probability of malignancy 
obtained from the network was 33.59% for patients 
without palpable neck lymph nodes. For the cases 
of high risk (left side), where patient characteristics 
are highly suggestive of malignancy based on 
known clinical factors, the global probability of 
malignancy obtained from the network was 75.54% 
for patients with palpable neck lymph nodes. 
Figure 2 shows the cumulative expected probability 
after adding each risk factor for malignancy using 
expert subjective probabilities, which resembles 
the clinical decision process. For example, the 
probability of malignancy of a male patient who is 
older than 60 years without palpable neck lymph 
nodes is 34%, and it increases to 48% if there are 
multiple nodules that are smaller than 1 cm, are 
hard and have a fast growth rate.
Discussion
Thyroid nodules are a common condition seen 
in surgical consultation. With the common and 
indiscriminate use of ultrasonography in patients 
without any thyroid symptoms, most thyroid nodules 
are diagnosed, and most decisions regarding the 
management of these patients should be made by 
surgeons (10).
The most important factor to assess in a patient with 
a thyroid nodule is the risk of malignancy, for which 
surgery is mandatory. In some geographic areas, 
goiter is an endemic condition, and approximately 
3 to 12% of nodules correspond to thyroid cancer 
(20,21). Classically, thyroid nodules have been 
assessed clinically to detect characteristics that 
could suggest a risk of malignancy. Young or 
older males with a solitary large and hard nodule 
with rapid growth associated with dysphonia or 
dysphagia, with a finding of neck lymph nodes 
and with a previous history of neck radiation or a 
parent who was diagnosed with thyroid cancer, are 
considered to have a high risk of malignancy. 
A patient with these typical characteristics is not 
commonly found during consultation, and most 
patients belong to a spectrum in which some of 
these factors are present while others not and the 
surgeon must individually assess the probability 
of malignancy to devise an appropriate diagnostic 
strategy (diagnostic threshold) or to determine an 
appropriate therapeutic intervention (therapeutic 
threshold). Usually, this decision is made based on 
a subjective evaluation of the risk of malignancy 
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associated with the nodule, as a grading scale 
based on objective probabilities using the data 
available in the literature is not regularly available 
in clinical settings. If we consider geographic areas 
with endemic goiter, the weight of the clinical factors 
on the perceived risk of malignancy could determine 
a more cost-effective use of diagnostic or therapeutic 
maneuvers in a patient with a thyroid nodule. 
In these cases, some useful alternatives to 
subjective probabilities are decision trees or 
bayesian networks. Bayesian networks in particular 
are considered to be more useful because they 
consider the value of probabilities a priori to 
the results and allow for the introduction of new 
information when calculating the final probabilities 
(a posteriori probabilities). The bayesian networks 
increase the ease of updating the malignancy 
Table 4. Combined probabilities for clinical cases combining individual probabilities shown in Table 3 *
Combined probabilities
 Medical cases Probability 
1 DD=HR, AS=HR, MA=HR, NC=HR, neck lymph node exists. 0.94 
2 DD=HR, AS=HR, MA=HR, NC=HR, neck lymph node does not exist. 0.74 
3 DD=HR, AS=HR, MA=HR, NC=LR, neck lymph node exists. 0.77 
4 DD=HR, AS=HR, MA=HR, NC=LR, neck lymph node does not exist. 0.63 
5 DD=HR, AS=HR, MA=LR, NC=HR, neck lymph node exists. 0.73 
6 DD=HR, AS=HR, MA=LR, NC=HR, neck lymph node does not exist. 0.47 
7 DD=HR, AS=HR, MA=LR, NC=LR, neck lymph node exists. 0.52 
8 DD=HR, AS=HR, MA=LR, NC=LR, neck lymph node does not exist. 0.44 
9 DD=HR, AS=LR, MA=HR, NC=HR, neck lymph node exists. 0.77 
10 DD=HR, AS=LR, MA=HR, NC=HR, neck lymph node does not exist. 0.63 
11 DD=HR, AS=LR, MA=HR, NC=LR, neck lymph node exists. 0.56 
12 DD=HR, AS=LR, MA=HR, NC=LR, neck lymph node does not exist. 0.48 
13 DD=HR, AS=LR, MA=LR, NC=HR, neck lymph node exists. 0.61 
14 DD=HR, AS=LR, MA=LR, NC=HR, neck lymph node does not exist. 0.39 
15 DD=HR, AS=LR, MA=LR, NC=LR, neck lymph node exists. 0.43 
16 DD=HR, AS=LR, MA=LR, NC=LR, neck lymph node does not exist. 0.16 
17 DD=LR, AS=HR, MA=HR, NC=HR, neck lymph node exists. 0.86 
18 DD=LR, AS=HR, MA=HR, NC=HR, neck lymph node does not exist. 0.69 
19 DD=LR, AS=HR, MA=HR, NC=LR, neck lymph node exists. 0.81 
20 DD=LR, AS=HR, MA=HR, NC=LR, neck lymph node does not exist. 0.67 
21 DD=LR, AS=HR, MA=LR, NC=HR, neck lymph node exists. 0.65 
22 DD=LR, AS=HR, MA=LR, NC=HR, neck lymph node does not exist. 0.66 
23 DD=LR, AS=HR, MA=LR, NC=LR, neck lymph node exists. 0.54 
24 DD=LR, AS=HR, MA=LR, NC=LR, neck lymph node does not exist. 0.51 
25 DD=LR, AS=LR, MA=HR, NC=HR, neck lymph node exists. 0.79 
26 DD=LR, AS=LR, MA=HR, NC=HR, neck lymph node does not exist.  0.32 
27 DD=LR, AS=LR, MA=HR, NC=LR, neck lymph node exists. 0.60 
28 DD=LR, AS=LR, MA=HR, NC=LR, neck lymph node does not exist. 0.35 
29 DD=LR, AS=LR, MA=LR, NC=HR, neck lymph node exists. 0.59 
30 DD=LR, AS=LR, MA=LR, NC=HR, neck lymph node does not exist.  0.31 
31 DD=LR, AS=LR, MA=LR, NC=LR, neck lymph node exists. 0.33 
32 DD=LR, AS=LR, MA=LR, NC=LR, neck lymph node does not exist. 0.19
* Only the cases of expected High incidence of malignancy are shown. The number shows the pooled probability after combining the 
probabilities shown in table 3 for each risk factor described in the row. 
HR: high risk, LR: low risk; DD: demographic data; AS: associated symptoms; MA: medical antecedents; NC: nodule’s 
characteristics 
probabilities when new patient data are collected 
and connect all the probabilities, the previous a 
priori probability and the influence that new data 
have on producing a posteriori probabilities. Each 
observation of an event can incrementally increase 
or decrease the confidence on a hypothesis or 
model. The bayesian network tool is significantly 
more flexible than rule-based algorithms, which 
reject a hypothesis completely when it is inconsistent 
with prior observations. Applications of bayesian 
networks are found in fault diagnosis for complex 
systems with multiple state variables and multiple 
causal dependencies. The Bayes methodology can 
be easily used in real-time classification systems 
under uncertain conditions. For these reasons, we 
used a bayesian network to approach the problem 
of the perception of risk of malignancy on thyroid 
nodules. We only found 8 studies in this field, 
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most of them using information from imaging tests 
or pathology reports. We considered laboratory 
information as a secondary step that should be 
applied after defining the risk of malignancy of the 
nodule (22-29).
Our results demonstrate that the perception of risk of 
thyroid nodules is overestimated. Raza, et al. (7), in 
a multivariable model from 600 patients, calculated 
risks of 15% and 99% when patients have either 
low or high risk factors, respectively. Tuttle, et al. 
(8) used a bayesian analysis in 1,121 patients to 
establish a risk of 3% and 80% in patients with low 
or high risk factors, respectively.
If we consider individual variables, as shown 
in table 3, lower risk factors, as may be seen in 
middle-aged female patients, are assigned a 
malignancy probability of 19%, a patient without 
risk factors, such as radiotherapy or family history, 
is assigned a probability of 25% or a patient with 
multiple nodules that are smaller than 1 cm and 
have a soft consistency is assigned a probability of 
Figure 2. Final results of probability of malignancy in a thyroid nodule, classified as low or high incidence according to clinically 
accepted risk factors.
20%, which are clearly higher than those reported 
in the literature, of finding carcinoma in an index 
nodule, which is approximately 5 to 15%. This 
was corroborated by the clinical cases, in which 
a patient without any risk factors is assigned a 
probability of malignancy of 19%, and in the final 
results that were obtained by the network, where a 
patient without risk factors has a basal probability 
of malignancy of 33%. 
If experts believe that the risk of malignancy of a 
thyroid nodule, even in a more favorable scenario, 
is as high as one in every three patients, he will 
use more diagnostic resources to confirm or rule 
out the diagnosis compared with a case with a 
lower perception of risk. Consequently, he will also 
communicate this perception to patients and other 
physicians, which may result in more diagnostic 
tests and a more aggressive therapy for patients.
Objective measures of risk as developed from cohort 
studies represent the real effect of some factors 
on the outcome. Translation of these measures to 
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clinical practice continues to present a challenge. 
Many researchers have found that although 
there is sufficient information to make decisions, 
physicians do not follow recommendations and 
guidelines (30,31). Some authors believe that the 
problem is related to the impossibility of delivering 
the information to the final decision maker, and 
tools have been developed, including electronic 
reminders or rewards on health care systems, with 
good results (32,33).
However, we suggest this problem should be 
approached from a different point of view. We 
believe that decision makers make decisions 
based on subjective beliefs that do not necessarily 
correspond to the objective measures of the effect 
(34,35). This study demonstrated the important 
role that subjective probabilities play in a surgeon’s 
analysis of thyroid nodules. Therefore, we consider 
that one alternative approach must be to identify 
these subjective beliefs and to develop specific 
informative or educational strategies to ensure 
that clinical decision making considers objective 
data as well as subjective probabilities. Bayesian 
analysis, as proposed in this study, could be used to 
identify incongruence between data and subjective 
probabilities and allows the development of more 
focused interventions.
In conclusion, this study using a bayesian network 
assesses the beliefs of experts about the variables 
that predict malignancy in thyroid nodules and 
demonstrates that significant differences exist 
between subjective beliefs and objective measures of 
risk as described by the literature. This disagreement 
should be explored to improve the process of making 
decisions concerning patients with thyroid nodules.
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